EU drug agency concludes that AstraZeneca benefits outweigh the risks 18-Mar-21 10:01 pm Analysis Anirudh Sethi But agency says it cannot definitively rule out a like to blood clotsRemains important to keep track of all side effectsWill continue to study possible links to blood clotsThis is not the definitive kind of ‘this is safe’ ruling we’d all like.